C.E.R.A. maintains stable hemoglobin in Latin American patients on dialysis

BACKGROUND: C.E.R.A. is a continuous erythropoietin receptor activator with characteristics that permit a once-monthly schedule of administration for the maintenance treatment for chronic kidney disease (CKD) patients. The main objective of this study was to assess the maintenance of Hb concentratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Bastos, Kleyton, Lucarelli, Luis Antonio, De Francesco-Daher, Elizabeth, Filho, Roberto Pecoits, Henríquez, Carlos, Espinoza, Beatriz, Villanueva, Ignacio, Schwedt, Emma, Schiavelli, Ruben, Correa-Rotter, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2012
Materias:
Nephrology - Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824352/
https://www.ncbi.nlm.nih.gov/pubmed/22990412
http://dx.doi.org/10.1007/s11255-012-0272-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824352/
https://www.ncbi.nlm.nih.gov/pubmed/22990412
http://dx.doi.org/10.1007/s11255-012-0272-3

Ejemplares similares